Literature DB >> 20516434

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib.

Kostandinos Sideras1, Michael E Menefee, Jill K Burton, Charles Erlichman, Keith C Bible, S Percy Ivy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20516434     DOI： 10.1200/JCO.2009.26.4432

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.

Authors:  Pamela Jo Harris; Keith C Bible
Journal:  Expert Opin Investig Drugs       Date:  2011-10       Impact factor: 6.206

Review 2.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

Review 3.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

4.  Rapid hair depigmentation in patient treated with pazopanib.

Authors:  Robert Šeparović; Mirjana Pavlović; Tajana Silovski; Ana Tečić Vuger
Journal:  BMJ Case Rep       Date:  2018-08-23

5.  Phototoxic Reaction Induced by Pazopanib.

Authors:  Siriorn Udompanich; Kumutnart Chanprapaph; Natta Rajatanavin
Journal:  Case Rep Dermatol       Date:  2018-11-21

6.  Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with pazopanib.

Authors:  Sharad Goyal; Sneha Shah; Atif J Khan; Hasan Danish; Bruce G Haffty
Journal:  ISRN Oncol       Date:  2012-12-06

Review 7.  Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer.

Authors:  Brittany A Davidson; Angeles Alvarez Secord
Journal:  Int J Womens Health       Date:  2014-03-13

Review 8.  Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.

Authors:  Tanner Fullmer; Maria E Cabanillas; Mark Zafereo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-15       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.